Sars-CoV-2/COVID-19 Ivermectin Navarra-ISGlobal Trial

NCT04390022 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

24

Enrollment

OTHER

Sponsor class

Conditions

Covid-19
Coronavirus Infection
SARS-CoV-2 Infection

Interventions

DRUG: Ivermectin
DRUG: Placebo

Sponsor

Clinica Universidad de Navarra, Universidad de Navarra

Collaborators

[object Object]